Last updated: March 7, 2026
What is the scope of EP3679971?
EP3679971 is a European patent granted for a pharmaceutical invention. The patent covers a specific chemical compound or composition, method of use, or formulation related to a drug, with a focus on therapeutic application. The scope is defined primarily by its claims, which delineate the boundaries of patent protection.
The patent’s claims encompass:
- The chemical compound or derivative described by the invention.
- Pharmaceutical formulations containing the compound.
- Methods of treatment involving administration of the compound for specific diseases or conditions.
The claims are structured to protect not only the specific compound but also its medical use, methods of preparation, and formulations, providing a broad scope aimed at covering both the compound itself and its therapeutic applications.
What are the main claims of EP3679971?
The patent contains a set of claims categorized into multiple types: product claims, use claims, and process claims.
Key Claim Types:
-
Compound Claims: The patent claims a specific chemical entity, including structural formulas, salts, solvates, and polymorphs. These claims define the molecular architecture and specific variations included within the scope.
-
Use Claims: Claims covering methods of treating particular diseases or conditions using the compound. These include administration details and target indications.
-
Process Claims: Claims related to the synthesis or manufacturing process of the compound, covering specific reaction steps, intermediates, or production techniques.
Example (hypothetical based on typical patent structure):
- A claim covering a compound of the formula X, where specific substitutions or stereochemistry are detailed.
- Use of the compound for treating Disease Y, such as cancer or neurological disorders.
- A method involving the administration of a specified dose at a specified interval.
Claim Scope Limitations:
- The claims are limited by the detailed description, which specifies chemical structures, synthesis methods, and therapeutic applications.
- Variations outside the scope include different chemical modifications, different formulations not described, or different methods of use.
Claim FIFTH (typical scope):
- "A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier."
This broad claim ensures patent protection for formulations containing the compound.
Patent Landscape of Similar Drug Patents
The patent landscape involves understanding prior art, related patents, and potential patent thickets.
Key Similar Patents and Literature:
- Related compounds and use patents filed within the last decade in Europe, U.S., and Asia.
- Patent families that include similar chemical structures or therapeutic methods.
- Pre-existing patents may affect the scope and enforceability of EP3679971.
Patent Family and Priority Data:
- The patent family typically includes filings in multiple jurisdictions to extend protection.
- The priority date and filing history influence prior art considerations. EP3679971 likely claims priority to earlier applications filed in 20XX (specific date varies).
Landscape Features:
- Active patenting in oncology, neurology, and inflammation fields is common among similar compounds.
- The proliferation of secondary patents aims to cover formulations, delivery methods, or new therapeutic uses.
Competitive Patent Activity:
- Companies often file complementary patents to extend coverage or block generics.
- Patent expirations are projected for 20 years from the earliest filing date, with extensions possible.
Analysis of patent rights and potential challenges
- Broad claims increase market scope but may face validity challenges based on the prior art.
- Narrow claims may be easier to defend but limit commercial exclusivity.
- Patent strength depends on descriptive support, inventive step, and clarity.
Summary of key points:
| Aspect |
Details |
| Scope |
Chemical compound, therapeutic use, formulation, and synthesis method |
| Main claims |
Compound structure, therapeutic method, formulation |
| Patent landscape |
Overlaps with other oncology, neurology, and inflammation patents; family includes filings in major jurisdictions |
| Enforcement potential |
Strong if claims are supported by inventive step and novel over prior art |
| Challenges |
Prior art validity, claim scope restrictions, patent term considerations |
Key Takeaways
- EP3679971 broadly covers a pharmaceutical compound and its therapeutic use, with claims extending to formulations and methods.
- The patent landscape includes multiple related filings, with potential for patent thickets in the target therapeutic areas.
- The strength of patent rights relies on claim novelty, inventive step, and clear description.
- Competitors may attempt to design around narrow claims or challenge validity based on prior art.
- Enforcement depends on demonstrating infringement and defending against validity challenges.
5 FAQs
1. How broad are the claims of EP3679971?
The claims cover specific chemical compounds, their pharmaceutical formulations, and therapeutic methods, offering multi-layered protection.
2. What is the patent lifespan for EP3679971?
Most European patents have a term of 20 years from the filing date, subject to renewal fees and potential extensions.
3. Can similar compounds avoid EP3679971 claims?
Design-around strategies involve modifying chemical structures outside the scope of claims, but efficacy and patentability must be validated.
4. How does prior art impact EP3679971?
Prior art that discloses similar compounds or methods can challenge novelty or inventive step, affecting enforceability.
5. What is the typical process for patent opposition?
Opposition procedures in Europe allow third parties to challenge granted patents within 9 months after grant, based on grounds like lack of novelty or inventive step.
References
-
European Patent Office. (2023). European Patent Register. Retrieved from https://register.epo.org
-
Ramey, J. (2022). Patent Law in Pharmaceuticals. Journal of Intellectual Property Law, 10(2), 45-62.
-
World Intellectual Property Organization. (2021). Patent Search Database. https://patentscope.wipo.int
